{
  "nct_id": "SAMPLE-002",
  "title": "A Randomized Open-Label, Active-Controlled Study of Drug-Y in Patients With Type 2 Diabetes",
  "indication": "Type 2 Diabetes",
  "phase": "Phase 3",
  "sample_size": 520,
  "duration_weeks": 52,
  "dropout_rate": 0.12,
  "primary_endpoints": ["HbA1c reduction"],
  "control_arm": "standard of care",
  "blinding": "open-label",
  "outcome_summary": "Primary endpoint met with statistical significance"
}